Janice Castillo

Statistics

Publications

Citations

1.3K

H-Index

Active since

2013

Affiliations

Portola Pharmaceuticals (United States)(Current)

McMaster University

Population Health Research Institute

Janice Castillo is an author at Portola Pharmaceuticals (United States) specializing in thrombosis prevention, antithrombotic therapy, and pharmacology.

Publications per year

2013–2020

Publications

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity

Deborah Siegal, John T. Curnutte, Stuart J. Connolly et al. · New England Journal of Medicine · 2015 · 1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal Of Rivaroxaban-Induced Anticoagulation In Healthy Subjects By Andexanet Alfa (PRT064445), An Antidote For Fxa Inhibitors

Mark Crowther, M. Manasar.Vandana, Michael Kitt et al. · Blood · 2013 · 115 citations

Medicine, Pharmacology, Pharmacotherapy +14

Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa

Deborah Siegal, Genmin Lu, Janet M. Leeds et al. · Blood Advances · 2017 · 74 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers

Genmin Lu, Pamela B. Conley, Janet M. Leeds et al. · Blood Advances · 2020 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

455

Mark Crowther, Genmin Lu, Pamela B. Conley et al. · Critical Care Medicine · 2014 · 39 citations

Humanities, Literature, Manuscript Studies +1

1–5 of 6